Frontlight ResearchEarly access
Endometrial cancer trials in Romania
1 trial · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 2/3Taking peopleStudy of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
- Where
- Bucharest, Constanța, Craiova, Piteşti, Timișoara
- Age
- 18 years and over
- People
- 268 worldwide
- Run by
- Kartos Therapeutics, Inc.
See details and how to joinNCT05797831